Best Performing Stocks To Invest In 2019

As you know, Amazon.com Inc. (NYSE: AMZN) is dominating the retail space right now, sending lesser companies to an early grave.

It’s not rocket science: Only those companies with the ingenuity to adapt to the brave new world of e-commerce will truly thrive, and that’s where your profit opportunity lies…

In fact, one of these clever firms just announced a new initiative in 100 cities… and Money Morning Capital Wave Strategist Shah Gilani isn’t about to leave money sitting on the table.

And you shouldn’t, either.

Shah appeared on FOX Business Network’s “Varney & Co.” just this morning to lay out the smartest strategy you can use to cash in on this particular retailer…

Video  You’re Cheating Yourself Out of One Monster Closeout After Another

Recently, a group of readers saw an incredible 1,156% windfall… but unfortunately, you weren’t one of them.

They’re a part of our top-performing research service – one that’s delivered total winning gains of 6,160% in less than a year (including partial closeouts)!

Best Performing Stocks To Invest In 2019: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Best Performing Stocks To Invest In 2019: Actuant Corporation(ATU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Eaton (NYSE: ETN) and Actuant (NYSE:ATU) are both industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Best Performing Stocks To Invest In 2019: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By ]

    WikiLeaks said it would “call for a global blockade of Coinbase” because it is “an unfit member of the crypto community.” It’s not the first time WikiLeaks has been reprimanded by a financial services provider, though – Mastercard Inc. (MA) and PayPal Holdings Inc. (PYPL) have both restricted WikiLeaks on their platforms.

  • [By Matthew Cochrane]

    The biggest threat facing Brink’s is the very nature of the industry it inhabits. While cash will, for the foreseeable future, probably serve a purpose in the global economy, I don’t think it can be argued that its use will soon be on the decline. Mastercard Inc (NYSE:MA) has long maintained that about 85% of the world’s transactions were facilitated using cash. Last year, the company updated that number to being just above 80% and, given current trends, I believe this number will continue to fall.

  • [By Matthew Cochrane]

    Let’s take a closer look at Corning Incorporated (NYSE:GLW), Mastercard Inc. (NYSE:MA), and Skyworks Solutions Inc. (NASDAQ:SWKS) so I can explain why I personally own all three and why, if you’re also in your 40s, you might want to consider them for your own portfolio.

Best Performing Stocks To Invest In 2019: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.